R5, contract pharma firm with cleanroom, launches

UK-based firm R5 Pharmaceuticals has launched its range of contract services in drug development for the pharma and biotech industry.

The company, based on the BioCity campus, Nottingham, offers an integrated approach to pharmaceutical development, from drug formulation and delivery technology through to full-scale manufacture, and provides solutions for the development of safe and effective pharmaceutical materials to be used in clinical studies.

R5 is also applying its expertise to new and rapidly evolving areas such as paediatric products and nutraceuticals, which are coming under increasing pharmaceutical regulation.

'The importance of formulation in the drug development process should never be underestimated. From the identification of initial targets and lead compounds to the creation of a tangible product with therapeutic benefit, verified as safe to use in humans, the early stages of drug development present a formidable challenge,' said Paul Titley, R5 ceo.

'It is clear that each stage requires thorough and efficient methodology, as well as high quality facilities and a strong team', Titley added.

The facilities include one of the very few cleanrooms in Europe, enabling the highest level of sterile product development.

Through the use of a pre-existing, purpose-built building, along with high spec, reclaimed equipment, R5 made a saving of nearly £5m in start-up costs.